Εμφανίζονται 1 - 4 Αποτελέσματα από 4 για την αναζήτηση '"методы экстракорпоральной гемокоррекции"', χρόνος αναζήτησης: 0,45δλ Περιορισμός αποτελεσμάτων
  1. 1
    Academic Journal

    Συνεισφορές: The study had no sponsorship, Исследование не имеет спонсорской поддержки

    Πηγή: Russian Sklifosovsky Journal "Emergency Medical Care"; Том 13, № 2 (2024); 186-195 ; Журнал им. Н.В. Склифосовского «Неотложная медицинская помощь»; Том 13, № 2 (2024); 186-195 ; 2541-8017 ; 2223-9022

    Περιγραφή αρχείου: application/pdf

    Relation: https://www.jnmp.ru/jour/article/view/1878/1455; Batlle D, Soler MJ, Sparks MA, Hiremath S, South AM, Welling PA, et al. Acute kidney injury in COVID-19: emerging evidence of a distinct pathophysiology. J Am Soc Nephrol. 2020;31(7):1380–1383. PMID: 32366514 doi:10.1681/ASN.2020040419; Gagliardi I, Patella G, Michael A, Serra R, Provenzano M, Andreucci M. COVID-19 and the kidney: from epidemiology to clinical practice. J Clin Med. 2020;9(8):2506. PMID: 32759645 doi:10.3390/jcm9082506; Fisher M, Neugarten J, Bellin E, Yunes M, Stahl L, Johns TS, et al. AKI in Hospitalized Patients with and without COVID-19: A Comparison Study. J Am Soc Nephrol. 2020;31(9):2145–2157. PMID: 32669322 doi:10.1681/ASN.2020040509; Ouyang L, Gong Y, Zhu Y, Gong J. Association of acute kidney injury with the severity and mortality of SARS-CoV-2 infection: A meta-analysis. Am J Emerg Med. 2021;43:149–157. PMID: 33046323 doi:10.1016/j.ajem.2020.08.089; Gabarre P, Dumas G, Dupont T, Darmon M, Azoulay E, Zafrani L. Acute kidney injury in critically ill patients with COVID-19. Intensive Care Med. 2020;46(7):1339–1348. PMID: 32533197 doi:10.1007/s00134-020-06153-9; Wang K, Chen W, Zhou Y-S, Lian J-Q, Zhang Z, Du P, et al. SARS-CoV-2 invades host cells via a novel route: CD147-spike protein. BioRxiv. The preprint server for biology. 2021. doi:10.1101/2020.03.14.988345 Available at: https://www.biorxiv.org/content/10.1101/2020.03.14.988345v1.full [Accessed 11 Jul 2023]; Vinayagam S, Sattu K. SARS-CoV-2 and coagulation disorders in different organs. Life Sci. 2020;260:118431. PMID: 32946915 doi:10.1016/j.lfs.2020.118431; Faour WH, Choaib A, Issa E, Choueiry FE, Shbaklo K, Alhajj M, et al. Mechanisms of COVID-19-induced kidney injury and current pharmacotherapies. Inflamm Res. 2022;71(1):39–56. PMID: 34802072 doi:10.1007/s00011-021-01520-8; Gaudino M, Chikwe J, Hameed I, Robinson NB, Fremes SE, Ruel M. Response of cardiac surgery units to COVID-19: an internationally-based quantitative survey. Circulation. 2020;142(3):300–302. PMID: 32392425 doi:10.1161/CIRCULATIONAHA.120.047865; Gupta AK, Leslie A, Hewitt JN, Kovoor JG, Ovenden CD, Edwards S, et al. Cardiac surgery on patients with COVID-19 : a systematic review and meta-analysis. ANZ J Surg. 2022;92(5):1007–1014. PMID: 35373439 doi:10.1111/ans.17667; Hu J, Chen R, Liu S, Yu X, Zou J, Ding X. Global incidence and outcomes of adult patients with acute kidney injury after cardiac surgery : a systematic review and meta-analysis. J Cardiothorac Vasc Anesth. 2016;30(1):82–89. PMID: 26482484 doi:10.1053/j.jvca.2015.06.017; Vandenberghe W, Gevaert S, Kellum JA, Bagshaw SM, Peperstraete H, Herck I, et al. Acute kidney injury in cardiorenal syndrome type 1 patients : a systematic review and meta-analysis. Cardiorenal Med. 2016;6(2):116–128. PMID: 26989397 doi:10.1159/000442300; Yu Y, Li C, Zhu S, Jin L, Hu Y, Ling X, et al. Diagnosis, pathophysiology and preventive strategies for cardiac surgery-associated acute kidney injury : a narrative review. Eur J Med Res. 2023;28(1):45. PMID: 36694233 doi:10.1186/s40001-023-00990-2; Временные методические рекомендации. Профилактика, диагностика и лечение новой коронавирусной инфекции. (COVID-19). Версия 16 (18. 08. 2022). URL: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/060/193/original/%D0%92%D0%9C%D0%A0_COVID-19_V16.pdf [Дата обращения 13 мая 2024 г.]; Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl. 2012;2(1Suppl):4–138.; Nadim MK, Forni LG, Mehta RL, Connor MJ Jr, Liu KD, Ostermann M, et al COVID-19-associated acute kidney injury: consensus report of the 25 th Acute Disease Quality Initiative (ADQI) Workgroup. Nat Rev Nephrol. 2020;16(12):747–764. PMID: 33060844 doi:10.1038/s41581-020-00356-5; Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13(10):818–829. PMID: 3928249; Nashef SA, Roques F, Michel F, Gauducheau E. European system for cardiac operative risk evaluation. Europ J Cardiothorac Surg. 1999;16(1):9–13. PMID: 10456395 doi:10.1016/S1010-7940(99)00134-7; Moosdorf R. Cardiac surgery during the COVID-19 pandemic. Herz. 2023;48(3):223–225. PMID: 37097474 doi:10.1007/s00059-023-05175-5; Kaplan EF, Strobel RJ, Young AM, Wisniewski AM, Ahmad RM, Mehaffey JH, et al. Cardiac Surgery Outcomes During the COVID-19 Pandemic Worsened Across All Socioeconomic Statuses. Ann Thorac Surg. 2023;115(6):1511–1518. PMID: 36696937 doi:10.1016/j.athoracsur.2022.12.042; Kellum J.A., Till OV, Mulligan G Targeting acute kidney injury in COVID-19. Nephrol Dial Transplant. 2020;35(10):1652–1662. PMID: 33022712 doi:10.1093/ndt/gfaa231; Geetha D, Kronbichler A, Rutter M, Bajpai D, Menez S, Weissenbacher A, et al. Impact of the COVID-19 pandemic on the kidney community: lessons learned and future directions. Nat Rev Nephrol. 2022;18(11):724–737. PMID: 36002770 doi:10.1038/s41581-022-00618-4; Lumlertgul N, Pirondini L, Cooney E, Kok W, Gregson J, Camporota L, et al. Acute kidney injury prevalence, progression and long-term outcomes in critically ill patients with COVID-19: a cohort study. Ann Intensive Care. 2021;11(1):123. PMID: 34357478 doi:10.1186/s13613-021-00914-5; Bagshaw SM, Wald R, Adhikari NKJ, Bellomo R, da Costa BR, Dreyfuss D, et al. Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury. N Engl J Med. 2020;383(3):240–251. PMID: 32668114 doi:10.1056/NEJMoa2000741; Gaudry S, Hajage D, Martin-Lefevre L, Lebbah S, Louis G, Moschietto S, et al. Comparison of two delayed strategies for renal replacement therapy initiation for severe acute kidney injury (AKIKI 2): a multicentre, open-label, randomised, controlled trial. Lancet. 2021;397(10281):1293–1300. PMID: 33812488 doi:10.1016/S0140-6736(21)00350-0; Pan HC, Chen YY, Tsai IJ, Shiao CC, Huang TM, Chan CK, et al. Accelerated versus standard initiation of renal replacement therapy for critically ill patients with acute kidney injury : a systematic review and meta-analysis of RCT studies. Crit Care. 2021;25(1):5. PMID: 33402204 doi:10.1186/s13054-020-03434-z; Luo S, Yang L, Wang C, Liu C, Li D. [Clinical observation of 6 severe COVID-19 patients treated with plasma exchange or tocilizumab]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020;49(2):227–231. [Article in Chinese] PMID: 32391669 doi:10.3785/j.issn.1008-9292.2020.03.06; Gluck WL, Callahan SP, Brevetta RA, Stenbit AE, Smith WM, Martin JC, Blenda AV, Arce S, Edenfield WJ. Efficacy of therapeutic plasma exchange in the treatment of penn class 3 and 4 cytokine release syndrome complicating COVID-19. Respir Med. 2020;175:106188. PMID: 33190086 doi:10.1016/j.rmed.2020.106188; Faqihi F, Alharthy A, Abdulaziz S, Balhamar A, Alomari A, AlAseri Z, et al. Therapeutic plasma exchange in patients with life-threatening COVID-19: a randomised controlled clinical trial. Int J Antimicrob Agents. 2021;57(5):106334. PMID: 33838224 doi:10.1016/j.ijantimicag.2021.106334; Wei S, Zhang Y, Zhai K, Li J, Li M, Yang J, et al. CytoSorb in patients with coronavirus disease 2019: A rapid evidence review and meta-analysis. Front Immunol. 2023;14:1067214. PMID: 36798138 doi:10.3389/fimmu.2023.1067214; Becker S, Lang H, Barbosa CV, Tian Z, Melk A, Schmidt BMW. Efficacy of CytoSorb® : a systematic review and meta-analysis. Crit Care. 2023;27(1):215. PMID: 37259160 doi:10.1186/s13054-023-04492-9; https://www.jnmp.ru/jour/article/view/1878

  2. 2
  3. 3
  4. 4